Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy

Acta Neurologica Scandinavica

Volumn 117, Issue 1, 2008, Pages 55-59

  Bauer, J ^a   Buchmuller L ^a   Reuber, M ^b   Burr, W ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Epilepsy; Monotherapy; Pharmacotherapy; Seizure control

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; EPILEPSY; FEMALE; GENERALIZED EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROGNOSIS; RETROSPECTIVE STUDY;

ADULT; ANTICONVULSANTS; CARBAMAZEPINE; COHORT STUDIES; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 37249009219     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00940.x     Document Type: Article

References (19)

1. Brodie MJ, Kwan P. Staged approach to epilepsy management. Neurology 2002 58 (Suppl.5 S2 8.
2. Marson AG, Al-Kharusi AM, Alwaidh M et al. Carbamazepine, gabapentin, lamotrigine, oxcarbazepine or topiramate for partial epilepsy: results from the SANAD trial. Lancet 2007 369 : 1000 15.
3. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ on behalf of the Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007 68 : 402 8.
4. Kwan P, Brodie MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001 357 : 216 22.
5. Bauer J, Isojärvi JIT, Herzog AG et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002 73 : 121 5.
6. Bauer J, Blumenthal S, Reuber M, Stoffel-Wagner B. Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology 2004 27 : 243 6.
7. Bauer J, Ben-Menachem E, Krämer G, Fryze W, Da Silva S, Kasteleijn-Nolst Trenite DGA. Levetiracetam: a long-term follow-up study of efficacy and safety. Acta Neurol Scand 2006 114 : 169 76.
8. Stephen LJ, Brodie MJ. Seizure freedom with more than one antiepileptic drug. Seizure 2002 11 : 349 51.
9. Mohanraj R, Brodie MJ. Pharmacological outcomes in newly diagnosed epilepsy. Epilepsy Behav 2005 6 : 382 7.
10. Nicolson A, Appleton RE, Chadwick DW, Smith DF. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies. J Neurol Neurosurg Psychiatry 2004 75 : 75 9.
11. Mohanraj R, Brodie MJ. Outcomes in newly diagnosed localization-related epilepsies. Seizure 2005 14 : 318 23.
12. Marson AG, Al-Kharusi AM, Alwaidh M et al. Valproate, lamotrigine, or topiramate for generalized and unclassifiable epilepsy: results from the SANAD trial. Lancet 2007 369 : 1016 26.
13. Prasad A, Kuzniecky RI, Knowlton RC et al. Evolving antiepileptic drug treatment in juvenile moyclonic epilepsy. Arch Neurol 2003 60 : 1100 5.
14. Delgado-Escueta AV, Enrile-Bascal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984 34 : 285 94.
15. Penry JK, Dean CJ, Reila AR. Juvenile myoclonic epilepsy: long-term response to therapy. Epilepsia 1989 30 (Suppl.4 S19 23.
16. Mohanraj R, Parker PG, Stephen LJ, Brodie MJ. Levetiracetam in refractory epilepsy: a prospective observational study. Seizure 2005 14 : 23 7.
17. French JA. Refractory epilepsy: one size does not fit all. Epilepsy Curr 2006 6 : 177 80.
18. Sillanpää M, Schmidt D. Natural history of treated childhood-onset epilepsy: a prospective, long-term population-based study. Brain 2006 129 : 617 24.
19. Luciano AL, Shorvon SD. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Ann Neurol 2007 epub ahead of print.